Literature DB >> 4145470

N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.

H Uehleke, S Tabarelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4145470     DOI： 10.1007/bf00501863

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  32 in total

1.  4,4'-Diaminodiphenyl sulphone: solubility and distribution in blood.

Authors:  C U LINDERSTROM-LANG; R F NAYLOR
Journal:  Biochem J       Date:  1962-06       Impact factor: 3.857

2.  Studies in sulphone therapy.

Authors:  J LOWE
Journal:  Lepr Rev       Date:  1952-01       Impact factor: 0.537

3.  Biochemical effects of aromatic amines. I. Methaemoglobinaemia, haemolysis and Heinz-body formation induced by 4,4'-diaminodiphenylsulphone.

Authors:  M Hjelm; C H de Verdier
Journal:  Biochem Pharmacol       Date:  1965-07       Impact factor: 5.858

4.  [Methemoglobin formation by sulfonamides in a system containing liver homogenates, erythrocytes, NADPH and oxygen].

Authors:  R K Thauer; A Meiforth; H Uehleke
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1965-12-06

5.  [Behavior of different microsomal drug oxidations following inactivation of cytochrome P-450 by UV-irradiation or deoxycholate treatment].

Authors:  H Uehleke; F Schnitger; K H Hellmer
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1970-12

Review 6.  The biochemical production of ferrihemoglobin-forming derivatives from aromatic amines, and mechanisms of ferrihemoglobin formation.

Authors:  M Kiese
Journal:  Pharmacol Rev       Date:  1966-09       Impact factor: 25.468

7.  Agranulocytosis due to dapsone.

Authors:  A J Ognibene
Journal:  Ann Intern Med       Date:  1970-04       Impact factor: 25.391

8.  The effects of diaphenylsulfone (DDS) against chloroquine-resistant Plasmodium falciparum.

Authors:  R L Degowin; R B Eppes; P E Carson; R D Powell
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

9.  The polymorphic acetylation of dapsone in man.

Authors:  R Gelber; J H Peters; G R Gordon; A J Glazko; L Levy
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

10.  The role of cytochrome P-450 in the N-oxidation of individual amines.

Authors:  H Uehleke
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922
View more
  11 in total

1.  The pharmacokinetics of dapsone after oral administration to healthy volunteers.

Authors:  F A Pieters; J Zuidema
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

2.  Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.

Authors:  R J Riley; P Roberts; M D Coleman; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

Review 3.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

4.  Serum hemopexin in patients with dermatitis herpetiformis on dapsone (di(4-aminophenyl)sulphone).

Authors:  W Kastrup; G Lindstedt; P A Lundberg; H Mobacken
Journal:  Arch Dermatol Res       Date:  1975-12-31       Impact factor: 3.017

5.  Renal and biliary disposition of dapsone in the dog.

Authors:  J T Biggs; A K Uher; L Levy; R D Gordon; J H Peters
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

6.  Studies on the mechanism of hepatic microsomal N-oxide formation. N-oxidation of NN-dimethylaniline by a reconstituted rabbit liver microsomal cytochrome P-448 enzyme system.

Authors:  P Hlavica; S Hülsmann
Journal:  Biochem J       Date:  1979-07-15       Impact factor: 3.857

Review 7.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 8.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

9.  An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.

Authors:  M D Tingle; M D Coleman; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

Review 10.  Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.

Authors:  Bernard J Brabin; Teunis A Eggelte; Monica Parise; Francine Verhoeff
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.